These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11188978)

  • 81. Implication of the subthalamic nucleus in the pathophysiology and pathogenesis of Parkinson's disease.
    Benazzouz A; Piallat B; Ni ZG; Koudsie A; Pollak P; Benabid AL
    Cell Transplant; 2000; 9(2):215-21. PubMed ID: 10811394
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Properties of oscillatory neuronal activity in the basal ganglia and thalamus in patients with Parkinson's disease.
    Du G; Zhuang P; Hallett M; Zhang YQ; Li JY; Li YJ
    Transl Neurodegener; 2018; 7():17. PubMed ID: 30065816
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder.
    Wichmann T; DeLong MR
    Ann N Y Acad Sci; 2003 Jun; 991():199-213. PubMed ID: 12846988
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [The currently accepted pathophysiological model underlying surgical management of Parkinson disease].
    Sobstyl M; Zabek M; Koziara H
    Neurol Neurochir Pol; 2003; 37(1):203-13. PubMed ID: 12910841
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The pathophysiological basis of sensory disturbances in Parkinson's disease.
    Juri C; Rodriguez-Oroz M; Obeso JA
    J Neurol Sci; 2010 Feb; 289(1-2):60-5. PubMed ID: 19758602
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Relative contributions of local cell and passing fiber activation and silencing to changes in thalamic fidelity during deep brain stimulation and lesioning: a computational modeling study.
    So RQ; Kent AR; Grill WM
    J Comput Neurosci; 2012 Jun; 32(3):499-519. PubMed ID: 21984318
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A computational model of Parkinsonian handwriting that highlights the role of the indirect pathway in the basal ganglia.
    Gangadhar G; Joseph D; Srinivasan AV; Subramanian D; Shivakeshavan RG; Shobana N; Chakravarthy VS
    Hum Mov Sci; 2009 Oct; 28(5):602-18. PubMed ID: 19720411
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Clinical pathophysiology of parkinsonian symptoms: from experiences of stereotaxic surgery].
    Miyashita N; Narabayashi H
    Nihon Rinsho; 2000 Oct; 58(10):1980-6. PubMed ID: 11068435
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Basal Ganglia and Circuit Function:How Does the Ablation or Deep Brain Stimulation(DBS)Work?].
    Murase N; Hirabayashi H
    No Shinkei Geka; 2021 Jul; 49(4):712-723. PubMed ID: 34376603
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Parkinson's disease: the disease concept, etiology and diagnostic bases].
    Kuno S
    Nihon Rinsho; 2004 Sep; 62(9):1603-7. PubMed ID: 15462372
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection.
    Rodriguez MC; Obeso JA; Olanow CW
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S175-88. PubMed ID: 9749591
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The origin of motor fluctuations in Parkinson's disease: importance of dopaminergic innervation and basal ganglia circuits.
    Obeso JA; Rodriguez-Oroz M; Marin C; Alonso F; Zamarbide I; Lanciego JL; Rodriguez-Diaz M
    Neurology; 2004 Jan; 62(1 Suppl 1):S17-30. PubMed ID: 14718677
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Origins of a repetitive and co-contractive biphasic pattern of muscle activation in Parkinson's disease.
    Cutsuridis V
    Neural Netw; 2011 Aug; 24(6):592-601. PubMed ID: 21447437
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cortico-basal ganglia and cortico-cerebellar circuits in Parkinson's disease: pathophysiology or compensation?
    Martinu K; Monchi O
    Behav Neurosci; 2013 Apr; 127(2):222-36. PubMed ID: 23244290
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Parkinson's disease: a major hypokinetic basal ganglia disorder.
    Sian J; Gerlach M; Youdim MB; Riederer P
    J Neural Transm (Vienna); 1999; 106(5-6):443-76. PubMed ID: 10443550
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Anatomo-functional basis for Parkinson's disease].
    Obeso JA; Luquín MR; Artieda J; Herrero MT; Pastor MA; Guridi J
    Arch Neurobiol (Madr); 1991; 54(6):272-6. PubMed ID: 1811458
    [No Abstract]   [Full Text] [Related]  

  • 97. Characterization of the thalamic-subthalamic circuit involved in the placebo response through single-neuron recording in Parkinson patients.
    Frisaldi E; Carlino E; Lanotte M; Lopiano L; Benedetti F
    Cortex; 2014 Nov; 60():3-9. PubMed ID: 24457096
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A new approach to understand the pathophysiology of Parkinson's disease.
    Nambu A
    J Neurol; 2005 Oct; 252 Suppl 4():IV1-IV4. PubMed ID: 16222431
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Emotion and basal ganglia (I): what can we learn from Parkinson's disease?].
    Dondaine T; Péron J
    Rev Neurol (Paris); 2012; 168(8-9):634-41. PubMed ID: 22898560
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Inhibiting Basal Ganglia Regions Reduces Syllable Sequencing Errors in Parkinson's Disease: A Computer Simulation Study.
    Senft V; Stewart TC; Bekolay T; Eliasmith C; Kröger BJ
    Front Comput Neurosci; 2018; 12():41. PubMed ID: 29928197
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.